Both in Pharmaceuticals
Xenon Pharmaceuticals vs AbCellera Biologics
Over the past year XENE returned +0.3% and ABCL returned +152.2%; their daily moves had a correlation of 0.14.
XENE +0.3% ABCL +152.2%Growth of $1, one year, split-adjusted
| Metric | XENE | ABCL |
|---|---|---|
| Price | $39.19 | $12.28 |
| Market cap | $3.80B | $3.98B |
| Today | +2.51% | +0.82% |
| 1 month | +7.2% | −6.6% |
| 6 months | −33.1% | +143.7% |
| Year to date | −12.6% | +259.1% |
| 1 year | −4.7% | +128.7% |
| Revenue growth (YoY) | — | −76.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −1368.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 60.1× |
| Net cash | $930.7M | $540.1M |
| Dividend yield | — | — |
| Volatility (60d) | 82.7% | 77.7% |
| Short % of float | 8.1% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).